Mereo Biopharma Group Plc Share Price

NASDAQ: MREO

Small Cap

$1.78

+0.05

(+2.89%)

Live

as on September 18, 2025 at 7:41 pm IST

$₹

Mereo Biopharma Group Plc Stock Performance

as on September 18, 2025 at 7:41 pm IST

Day's Low
$1.75
Day's Price Range
$1.78
$1.78
1.69%
Downside
52 Week's Low
52 Week's High
$1.47
52-Week Price Range
$4.72
$1.78
17.42%
Downside
165.17%
Upside

Mereo Biopharma Group Plc share price movements today

Previous Close: $1.73
Open: $1.76
Volume: 129.4K
Day's Low - High: $1.75 - $1.78
52 Week Low - High: $1.47 - $4.72

Mereo Biopharma Group Plc Historical Returns

1 Month Return: + 2.98 %
3 Month Return: -39.72 %
1 Year Return: -59 %
3 Year Return: + 63.21 %
5 Year Return: -41.95 %

Mereo Biopharma Group Plc Stock Fundamentals & Key Indicators

Check Mereo Biopharma Group Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$275.2M

EPS (TTM)

-0.0318

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-44.0M

Revenue (TTM)

500.0K

Profit Margin

0.00%

Return On Equity TTM

2509600.00%

Mereo Biopharma Group Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mereo Biopharma Group Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Mereo Biopharma Group Plc	BUY	$275.2M	-41.95%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Mereo Biopharma Group Plc Stock including INR - Dollar returns

The Mereo Biopharma Group Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y

Mereo Biopharma Group Plc investment value today

Current value as on today

₹47,133

Returns

₹52,867

(-52.87%)

Returns from Mereo Biopharma Group Plc Stock

₹57,820 (-57.82%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Mereo Biopharma Group Plc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Mereo Biopharma Group Plc. Average target price of $7.19

Mereo Biopharma Group Plc Share Price Target

Get share price movements and forecasts by analysts on Mereo Biopharma Group Plc.

What analysts predicted

75.24%UPSIDE

Target Price

$7.19

Current Price

$1.78

Analyzed by

10 Analysts

Target

$7.19

Mereo Biopharma Group Plc target price $7.19, a slight upside of 75.24% compared to current price of $1.78. According to 10 analysts rating.

Mereo Biopharma Group Plc Stock's Interest Amongst Investors

Search interest for Mereo Biopharma Group Plc Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-39% versus previous 30 day period

Mereo Biopharma Group Plc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	4	11	0	0	-	-	-	1	-	0
Gross Profit	2	6	0	0	0	0	0	0	0	0
Operating Income	-4	-15	-6	-5	-9	-12	-9	-15	-11	-10
EBITDA	-10	0	-7	-7	-8	-12	-14	-6	-11	-14
Interest Expense	0	1	0	4	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-14	-6	-5	-8	-12	-15	-7	-12	-14
Income Tax Expense	0	-1	0	0	0	0	-15	0	-	-
Net Income	-6	-17	-6	-6	-8	-12	-15	-7	-12	-14
Net Profit Margin	-154.74%	-154.74%	-1229.72%	-1674.49%	0.00%	0.00%	0.00%	-662.06%	0.00%	-2923.20%

Mereo Biopharma Group Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-4	-	0	0	48	1	10	-
Gross Profit	-	-30	-50	-28	-31	-21	24	0	7	-1
Operating Income	-13	-36	-45	-35	-39	-37	-20	-43	-28	-47
EBITDA	-	-38	-44	-34	-37	-37	-5	-42	-26	-42
Interest Expense	-	0	1	2	3	6	5	3	2	1
Depreciation	-	-	0	0	1	1	0	0	1	1
Income Before Tax	-13	-33	-46	-37	-41	-166	14	-36	-29	-43
Income Tax Expense	-1	-5	-8	-5	-6	-2	1	-1	0	0
Net Income	-18	-35	-52	-40	-45	-219	16	-41	-29	-43
Net Profit Margin	0.00%	0.00%	1180.99%	0.00%	28560.66%	-41635.62%	34.90%	-2269.14%	-294.66%	0.00%

Mereo Biopharma Group Plc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-13	-8	-7	-8	-12	-15	-7	-12	-14
Operating Cash Flow	-16	-2	-2	-7	-7	-7	-9	-8	-7
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	0	4	4	-	46	0	0	0	0
Change in Cash	-14	3	3	-8	38	-6	-10	-7	-6

Mereo Biopharma Group Plc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-33	-46	-37	-41	-166	14	-36	-29	-43
Operating Cash Flow	-27	-32	-23	-45	-28	-5	-38	-21	-32
Investing Cash Flow	0	-3	0	43	1	0	1	0	0
Financing Cash Flow	68	33	-2	-5	34	77	0	7	46
Change in Cash	41	-3	-25	-8	7	70	-37	-10	12

Global Institutional Holdings in Mereo Biopharma Group Plc

Funds	Holdings
HHG PLC	14.3%
Rubric Capital Management LP	9.63%
Mangrove Partners	5.43%
Deerfield Management Co	4.22%
Rock Springs Capital Management LP	4.2%

See all

Insights on Mereo Biopharma Group Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 127.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 48.3%
NEGATIVE IMPACT
Price Dip
In the last 3 months, MREO stock has moved down by -39.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.06M → 500.0K (in $), with an average decrease of 53.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -7.04M → -14.61M (in $), with an average decrease of 48.2% per quarter

About Mereo Biopharma Group Plc

mereo is a new uk-based speciality biopharmaceutical company focussed on the acquisition and rapid development of innovative medicines that have the potential to transform patient quality of life and improve human health. mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or, for selected opportunities, commercialising products itself. mereo is building a strong pipeline of innovative medicines, particularly focused in rare and specialist disease areas, through the acquisition of validated, mid-stage development programmes from large biopharmaceutical companies. mereo has access to an extensive network of experts with experience across multiple clinical disciplines for the clinical development of its portfolio.

Organisation	Mereo Biopharma Group Plc
Headquarters	One Cavendish Place, London, United Kingdom, W1G 0QF
Industry	Biotechnology
CEO	Dr. Denise Vera Scots-Knight Ph.D.
E-voting on shares	Click here to vote

Key Management of Mereo Biopharma Group Plc

Name	Title
Dr. John P. Richard M.B.A.	Co-Founder & Chief Business Officer
Dr. John A. Lewicki Ph.D.	Chief Scientific Officer
Dr. Jackie Parkin	Senior VP & Therapeutic Head
Ms. Alexandra Hughes-Wilson	Chief of Patient Access & Commercial Planning
Mr. Bo Kara	Senior VP and Head of Pharmaceutical Development & CMC
Dr. Denise Vera Scots-Knight Ph.D.	Co-Founder, CEO & Executive Director
Mr. Charles Edward Sermon	Co-Founder, General Counsel, Business Development & Company Secretary
Ms. Christine Fox CPA	Chief Financial Officer

FAQs

What is Mereo Biopharma Group Plc share price today?

Mereo Biopharma Group Plc share price today is $1.78 as on September 18, 2025 at 7:41 pm IST. Mereo Biopharma Group Plc share today touched a day high of $1.78 and a low of $1.75.

What is the 52 week high and 52 week low for Mereo Biopharma Group Plc share?

Mereo Biopharma Group Plc share touched a 52 week high of $4.72 on October 21, 2024 and a 52 week low of $1.47 on August 12, 2025. Mereo Biopharma Group Plc stock price today i.e. September 18, 2025 at 7:41 pm IST is trending at $1.78,which is 62.29% down from its 52 week high and 21.09% up from its 52 week low.

What is Mereo Biopharma Group Plc's market capitalisation today?

Mereo Biopharma Group Plc market capitalisation is $0.00T as on September 18, 2025 at 7:41 pm IST.

How to invest in Mereo Biopharma Group Plc Stock (MREO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Mereo Biopharma Group Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mereo Biopharma Group Plc Shares that will get you 0.8427 shares as per Mereo Biopharma Group Plc share price of $1.78 per share as on September 18, 2025 at 7:41 pm IST.

What is the minimum amount required to buy Mereo Biopharma Group Plc Stock (MREO) from India?

Indian investors can start investing in Mereo Biopharma Group Plc (MREO) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Mereo Biopharma Group Plc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 7:41 pm IST). Based on Mereo Biopharma Group Plc share’s latest price of $1.78 as on September 18, 2025 at 7:41 pm IST, you will get 5.6180 shares of Mereo Biopharma Group Plc. Learn more about fractional shares .

What are the returns that Mereo Biopharma Group Plc has given to Indian investors in the last 5 years?

Mereo Biopharma Group Plc stock has given -41.95% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?